Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0E9.F
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -47.89 0.14 0.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -43.29 -0.92 -0.64
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -60.21 -0.02 -0.01
Cash 47.21 -0.02 0.01
Capex 0.00 0.00 0.00
Free Cash Flow 65.94 < 0.005 -0.02
Revenue 0.00 0.00 0.00
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.00 0.00 0.00
Operating Margin 0.00 0.00 0.00
ROA -86.03 -0.78 -0.42
ROE -40.54 2.03 3.42
ROIC 765.59 20.19 -2.33
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0E9.F is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0E9.F is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0E9.F is permitted for members.